The downstream effects of leptin signaling, through the activation of specific signaling pathways in tumor cells, such as the JAK/STAT3 and PI3K/AKT pathways, can promote carcinogenesis [83,182,214,215,216,217]. Here, LEP is linked to neoplasm.